Skip to main content
Veterinary Medicines

Ultrapen vet 300 mg/ml Injektionsvätska, suspension

Authorised
  • Benzylpenicillin procaine monohydrate

Product identification

Medicine name:
Ultrapen vet 300 mg/ml Injektionsvätska, suspension
Active substance:
  • Benzylpenicillin procaine monohydrate
Target species:
  • Sheep
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Benzylpenicillin procaine monohydrate
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Milk
        4
        day
      • Meat and offal
        28
        day
    • Cattle
      • Milk
        4
        day
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CE09
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 57788
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."